Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Fisabio and UMH request the patent of several compounds against the enzyme CDK4, key in aggressive and resistant cancers

Summary by RUVID
A team of researchers from the Miguel Hernández de Elche University (UMH) and the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio), from the Ministry of Health, has identified several molecules that could slow cellular proliferation leading to the growth of tumors called glioblastomas, as well as other types of cancer. Researchers from the Elche Institute for Research, Development and Innovation…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)